(Q34013180)

30 July 2017

Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance (English)

1 reference

30 July 2017

Antje Knöll

1

1 reference

30 July 2017

Arndt Hartmann

2

1 reference

30 July 2017

Harald Hamoshi

3

1 reference

30 July 2017

Karin Weislmaier

4

1 reference

30 July 2017

Wolfgang Jilg

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

World Journal of Gastroenterology

30 July 2017

1 reference

30 July 2017

12

1 reference

30 July 2017

8

1 reference

30 July 2017

1255-1260

1 reference

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124438

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124438

Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124438

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124438

Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124438

Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR).

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

Detection of HBs antigen in "anti-HBc alone" positive sera

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

The long-term course of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I8.1255

Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124438

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124438

Natural History of Hepatitis B Virus Infection in Renal Transplant Recipients-A Fifteen-Year Follow-Up

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124438

Prevalence of markers of hepatitis B in the adult German population

29 October 2018

1 reference

12 December 2020

NAT for HBV and anti-HBc testing increase blood safety

1 reference

12 December 2020

Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders

1 reference

12 December 2020

High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen

1 reference

12 December 2020

Serological pattern ?anti-HBc alone?: Report on a workshop

1 reference

12 December 2020

Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I8.1255

1 reference

30 July 2017

1 reference

30 July 2017

1 reference